Exact Sciences | EXAS - Current Liabilities

Exact Sciences reported $412.75M in Current Liabilities for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Liabilities Change
Accelerate Diagnostics AXDX:US USD 66.08M 55.36M
Agilent A:US USD 1.94B 75M
Becton, Dickinson and BDX:US USD 7.63B 186M
Bio Rad Laboratories BIO:US USD 568.71M 1.97M
Bio Techne TECH:US USD 128.39M 9.23M
Biocept BIOC:US USD 7.15M 2.46M
Bruker BRKR:US USD 913.8M 49.2M
Charles River Laboratories CRL:US USD 1.09B 77.39M
Danaher DHR:US USD 8.39B 387M
Exact Sciences EXAS:US USD 412.75M 10.93M
Hologic HOLX:US USD 956.2M 18.5M
Illumina ILMN:US USD 2.77B 104M
Mesa Laboratories MLAB:US USD 41.62M 111K
Mettler Toledo International MTD:US USD 1.15B 17.21M
Myriad Genetics MYGN:US USD 137.2M 8.1M
Nanostring Technologies NSTG:US USD 58.86M 7.92M
Orasure Technologies OSUR:US USD 70.39M 1.3M
Perkinelmer PKI:US USD 1.57B 80.77M
Quidel QDEL:US USD 1.19B 320.7M
Repligen RGEN:US USD 404.2M 6.5M
Staar Surgical STAA:US USD 51.72M 6.4M
Thermo Fisher Scientific TMO:US USD 17.11B 6B
Veracyte VCYT:US USD 62.61M 4.26M